Quantcast

Latest Tissue engineering Stories

2015-05-04 08:29:52

ROCKVILLE, Md., May 4, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc.

2015-04-29 23:10:40

Stem cell medicine technology start-up company Asymmetrex, LLC faces the unusual challenge of wishing to evaluate its new biomarker technologies, developed to count tissue stem cells for the first

2015-04-24 16:25:27

Introduced in 2014, MEND(TM) from Nutrition For Healing®, finds growing demand with Orthopedic Surgeons NEW YORK, April 24, 2015 /PRNewswire-iReach/ -- Nutrition For Healing®

wrinkled graphene
2015-04-24 09:43:07

For the last ten years or so, scientists have been looking for ways of culturing cells in laboratory settings that better reflect that complexity. Researchers from Brown University have recently made a major breakthrough in the search. They have developed a technique which creates tiny wrinkles in sheets of graphene. This produces new textured surfaces for culturing cells.

2015-04-22 23:10:45

In a recent interview, Asymmetrex, LLC founder and director James L. Sherley, M.D., Ph.D.

heart lungs
2015-04-22 09:18:23

Researchers from the Wake Forest Institute for Regenerative Medicine have developed tiny, 3D-printed organ-like objects that can mimic the function of the heart and lungs that they hope could be used to create an accurate model of the human body for research purposes.

2015-04-22 08:34:28

NEW YORK, April 22, 2015 /PRNewswire/ -- PharmaCyte Biotech, Inc. (OTCMRKTS: PMCB) is a Biotechnology company that was founded in 1996 in Maryland.

2015-04-09 23:05:42

Well-characterized and high-volume living cell systems provide engineered solutions for rapid product development and commercial translation Frederick, MD (PRWEB)

2015-03-30 12:30:35

Internationally Recognized Researcher in Bio-Inspired Materials and Bio-Materials Fields Adds New Functional Knowledge Depth IRVINE, Calif., March 30, 2015 /PRNewswire/ -- NuGene International,

2015-03-18 23:05:00

32 company presentations and five expert-led sessions will cover the future outlook for the industry, commercialization and market access strategies, capital markets, gene therapy delivery and